Forge Biologics logo
Startup

Forge Biologics

See Forge Biologics's full profile

BOOK A DEMO
Headquarters

United States

Founded Year

2020

Total Funding

$160.0M

Employees

51 - 200

Status

Active


About Forge Biologics

Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups.

Headquarters

United States


General Information on Forge Biologics

Brand name Forge Biologics
Company name Forge Biologics Holdings LLC
Website https://www.forgebiologics.com/
Founded year 2020
Employees 51 - 200
Founding team

Erandi De Silva

Jaysson Eicholtz

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Forge Biologics

StreetInsider 31.05.2022
Forge Biologics to Present at Annual Jefferies Global Healthcare Conference

Miller, Ph.D., CEO, President, and Co-Founder of Forge Biologics, will be presenting at the Jefferies 2022 Global Healthcare Conference on Wednesday, June 8, 2022, 3:00-3:25 p.m. Eastern Time. “Forge has grown to over 220 employees and we're excited to share how we are enabling manufacturing success for our gene therapy clients,” said Dr. Miller. “We have made considerable progress expanding to 20 cGMP suites, installed multiple 500L, 1000L, ...

Forge Biologics news
Manchester Times 18.05.2022
Forge Biologics bildet unabhängiges wissenschaftliches und produktionstechnisches Beratungsgremium mit führenden Vertretern der Gentherapie

Diese Pressemitteilung enthält multimediale Inhalte. Die vollständige Mitteilung hier ansehen: Credit: Forge Biologics „Wir freuen uns und fühlen uns geehrt, eine so renommierte Gruppe von Experten für die Entwicklung und Herstellung von Gentherapien um uns herum versammelt zu haben, die mit uns zusammenarbeiten, damit wir unseren Kunden Qualitätsprodukte liefern können, zumal wir die AAV-Produktion mit unserem neuen 5000-Liter-Bioreaktor ...

Kulr 8 News 17.05.2022
Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders

Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today the formation of an independent board of preeminent experts, a Scientific and Manufacturing Advisory Board (SMAB), to advise the Company on its gene therapy manufacturing offerings and therapeutics pipeline development. The board will serve the traditional functions of a scientific advisory board, with a distinct and strategic emphasis on ...

Forge Biologics news
Novum PR 17.05.2022
Forge Biologics vormt onafhankelijke wetenschappelijke en productieadviesraad met panel van gentherapie leiders Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders

COLUMBUS, Ohio–(BUSINESS WIRE)– Forge Biologics, een op gentherapie gerichte contract ontwikkelings- en productieorganisatie, heeft vandaag de vorming aangekondigd van een onafhankelijke raad van vooraanstaande experts, een Scientific en Manufacturing Advisory Board (SMAB), om het bedrijf te adviseren over zijn productie-aanbod voor gentherapie en de ontwikkeling van de pijplijn voor therapieën. Het bestuur zal de traditionele functies vervullen ...

Forge Biologics news
World Pharma Today 03.03.2022
Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership

Biologics, a gene therapy-focused contract development and manufacturing organization, announced a manufacturing partnership that will advance Ray Therapeutics' lead optogenetics gene therapy program, Ray-001, into clinical trials for patients with retinitis pigmentosa. Forge will provide adeno-associated viral (AAV) process development, scale-up engineering and cGMP manufacturing services for Ray Therapeutics' program, Ray-001. The program ...

Forge Biologics news
The Register-Herald 05.01.2022
Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference Jan 5, 2022 Jan 5, 2022 Updated 3 hrs ago

Miller, Ph.D., CEO, President, and Co-Founder, will present at the 40 th Annual J.P. Morgan Healthcare Conference virtually on Tuesday, January 11, 2022, at 10:00 a.m. Eastern Time. The presentation will be available on the Events section of the Forge Biologics website ( https://www.forgebiologics.com/news/#events ) on January 11 and for 30 days following the event. About Forge Biologics Forge Biologics is a hybrid gene therapy contract ...

Forge Biologics news
The Valdosta Daily Times 05.01.2022
Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference

The presentation will be available on the Events section of the Forge Biologics website ( https://www.forgebiologics.com/news/#events ) on January 11 and for 30 days following the event. About Forge Biologics Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 175,000 square ...

Financialbuzz.com 12.10.2021
Forge Biologics to Present at 2021 Cell & Gene Meeting on the Mesa

Miller, Ph.D., CEO, President and Co-Founder, will discuss Forge's robust AAV manufacturing solutions, proprietary technology advancements, and clinical development during a company presentation at Cell & Gene Meeting on the Mesa on October 12 at 5:00 p.m. PT. Dr. Miller will also join a panel of gene therapy experts for a discussion on “Dosing & Redosing in Gene Therapy,” October 14 at 11:00 a.m. PT. The conference will take place October ...

The Bakersfield 11.10.2021
Forge Biologics to Present at 2021 Cell & Gene Meeting on the Mesa Coronavirus Cases widget

Dr. Miller will also join a panel of gene therapy experts for a discussion on “Dosing & Redosing in Gene Therapy,” October 14 at 11:00 a.m. PT.The conference will take place October 12-14, 2021, at the Park Hyatt Aviara, in Carlsbad, California. To learn more about the event and registration, please visit: https://meetingonthemesa.com.Forge will be taking meetings during Meeting on the Mesa. Please contact John Maslowski, Chief Commercial ...